Community-based primary prevention programs decrease the rate of metabolic syndrome among socioeconomically disadvantaged women

Journal of Women's Health

Volumn 22, Issue 4, 2013, Pages 322-329

  Gilstrap, Lauren Gray ^a   Malhotra, Rajeev ^a   Peltier Saxe, Donna ^a   Slicas, Donna ^a   Pineda, Eliana ^a   Culhane Hermann, Catherine ^a   Cook, Nakela ^b   Fernandez Golarz, Carina ^a   Wood, Malissa ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANXIETY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOLOGIST; COMMUNITY PROGRAM; DEPRESSION; EXERCISE; FEMALE; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HEALTH PROGRAM; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MINORITY GROUP; NUTRITION; PHYSIOTHERAPIST; PRIMARY PREVENTION; PRIORITY JOURNAL; SOCIAL STATUS; STRESS;

ADOLESCENT; ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MASS SCREENING; NORTH CAROLINA; POVERTY AREAS; PREGNANCY; REPRODUCTIVE HEALTH; RISK FACTORS;

EID: 84876228947     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.3854     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention (CDC). Heart disease and stroke prevention: Addressing the nation's leading killers. At a glance 2009. Available at: http:// www.cdc.gov/chronicdisease/resources/publications/aag/ pdf/2011/Heart-Disease-and-Stroke-AAG-2011.pdf Accessed March 21, 2013.
2. Centers for Disease Control and Prevention (CDC). Chronic Disease Prevention and Health Promotion. Heart Disease and Stroke Prevention. Addressing the Nation's Leading Killers: At a glance 2011. Available at: http://www.cdc .gov/chronicdisease/resources/publications/A AG /dhdsp. htm Accessed March 21, 2013.
3. Roger VL, et al. (for writing group members). American Heart Association (AHA) Heart & Stroke 2012 Statistical Update. Circulation 2012 Jan 3;125(1):e2-e220. Available at: http://circ.ahajournals.org/content/125/1/e2 Accessed March 21, 2013.
4. Lindsay RS, Howard BV. Cardiovascular risk associated with the metabolic syndrome. Curr Diab Rep 2004;4:63-68.
5. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syn-drome. Lancet 2005;365:1415-1428.
6. Manson JE, Skerrett PJ, Greenland P, et al. The escalating pandemics of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med 2004;164:249-258.
7. Grundy SM, Brewer HB, Jr., Cleeman JI, et al. Definition of metabolic syndrome: Report of the national heart, lung, and blood institute/american heart association conference on sci-entific issues related to definition. Circulation 2004;109:433-438.
8. Hedner T, Hansson L, Jern S. What is happening to blood pressure? Blood Press 1996;5:132-133.
9. Sjol A, Thomsen KK, Schroll M. Secular trends in blood pressure levels in denmark 1964-1991. Int. J Epidemiol 1998; 27:614-622.
10. Burt VL, Cutler JA, Higgins M, et al. Trends in the preva-lence, awareness, treatment, and control of hypertension in the adult us population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-69.
11. Vadheim LM, Brewer KA, Kassner DR, et al. Effectiveness of a lifestyle intervention program among persons at high risk for cardiovascular disease and diabetes in a rural commu-nity. J Rural Health 2010;26:266-272.
12. Will JC, Massoudi B, Mokdad A, et al. Reducing risk for cardiovascular disease in uninsured women: Combined re-sults from two wisewoman projects. J Am Med Womens Assoc 2001;56:161-165.
13. Stoddard AM, Palombo R, Troped PJ, et al. Cardiovascular disease risk reduction: The massachusetts wisewoman pro-ject. J Womens Health (Larchmt) 2004;13:539-546.
14. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007;115:1481-1501.
15. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women\-2011 update: A guideline from the American Heart Association. J Am. Coll Cardiol 2011;57:1404-1423.
16. Spielberger CD, Vagg PR. Psychometric properties of the stai: A reply to Ramanaiah, Franzen, and Schill. J Pers Assess 1984;48:95-97.
17. Radloff LS, Rae DS. Susceptibility and precipitating factors in depression: Sex differences and similarities. J Abnorm Psychol 1979;88:174-181.
18. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-396.
19. Gillett MJ. International expert committee report on the role of the a1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334.
20. Diagnosis and classification of diabetes mellitus. Diabetes Care33;Suppl 1:S62-69.
21. Eaker ED, Chesebro JH, Sacks FM, et al. Cardiovascular disease in women. Circulation 1993;88:1999-2009.
22. Wenger NK. Coronary heart disease and women: Magni-tude of the problem. Cardiol Rev 2002;10:211-213.
23. Griffin BP, Rimmerman, C.M. and Topol, EJ. The Cleveland Clinic cardiology board review. 2nd edn. Section IX, Chapter 56, Women and heart disease. Philadelphia: Lippincott, Williams & Wilkins, 2006:833-843.
24. Ford ES. Risks for all-cause mortality, cardiovascular dis-ease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005;28:1769-1778.
25. Gami AS, Witt BJ, Howard DE, et al. EMetabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-414.
26. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am J Med 2006;119:812-819.
27. Hanson RL, Imperatore G, Bennett PH, et al. Components of the ''metabolic syndrome'' and incidence of type 2 diabetes. Diabetes 2002;51:3120-3127.
28. Resnick HE, Jones K, Ruotolo G, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: The strong heart study. Diabetes Care 2003;26:861-867.
29. Sattar N, Gaw A, Scherbakova O, et al. Metabolic syndrome with and without c-reactive protein as a predictor of coro-nary heart disease and diabetes in the west of scotland coronary prevention study. Circulation 2003;108:414-419.
30. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among us adults: Findings from the third national health and nutrition examination survey. J Am Med Assoc 2002;287:356-359.
31. Misra A, Khurana L. The metabolic syndrome in south asians: Epidemiology, determinants, and prevention. Metab Syndr Relat Disord 2009;7:497-514.
32. Stewart-Knox BJ. Psychological underpinnings of metabolic syndrome. Proc Nutr Soc 2005;64:363-369.
33. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome. Lancet 2005;366:1921-1922; author reply 1923-1924.
34. Kahn R. Metabolic syndrome\-what is the clinical useful-ness? Lancet 2008;371:1892-1893.
35. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: Time for a critical appraisal: Joint statement from the amer-ican diabetes association and the European association for the study of diabetes. Diabetes Care 2005;28:2289-2304.